These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 24421401

  • 1. Regulator of G-protein signaling 6 (RGS6) promotes anxiety and depression by attenuating serotonin-mediated activation of the 5-HT(1A) receptor-adenylyl cyclase axis.
    Stewart A, Maity B, Wunsch AM, Meng F, Wu Q, Wemmie JA, Fisher RA.
    FASEB J; 2014 Apr; 28(4):1735-44. PubMed ID: 24421401
    [Abstract] [Full Text] [Related]

  • 2. Neuronal nitric oxide synthase alteration accounts for the role of 5-HT1A receptor in modulating anxiety-related behaviors.
    Zhang J, Huang XY, Ye ML, Luo CX, Wu HY, Hu Y, Zhou QG, Wu DL, Zhu LJ, Zhu DY.
    J Neurosci; 2010 Feb 17; 30(7):2433-41. PubMed ID: 20164327
    [Abstract] [Full Text] [Related]

  • 3. RGS inhibition at G(alpha)i2 selectively potentiates 5-HT1A-mediated antidepressant effects.
    Talbot JN, Jutkiewicz EM, Graves SM, Clemans CF, Nicol MR, Mortensen RM, Huang X, Neubig RR, Traynor JR.
    Proc Natl Acad Sci U S A; 2010 Jun 15; 107(24):11086-91. PubMed ID: 20534514
    [Abstract] [Full Text] [Related]

  • 4. 5-HT1A receptors are differentially involved in the anxiolytic- and antidepressant-like effects of 8-OH-DPAT and fluoxetine in the rat.
    De Vry J, Schreiber R, Melon C, Dalmus M, Jentzsch KR.
    Eur Neuropsychopharmacol; 2004 Dec 15; 14(6):487-95. PubMed ID: 15589388
    [Abstract] [Full Text] [Related]

  • 5. Assessment of the serotonin reuptake blocking property of YM992: electrophysiological studies in the rat hippocampus and dorsal raphe.
    Dong J, De Montigny C, Blier P.
    Synapse; 1999 Dec 15; 34(4):277-89. PubMed ID: 10529722
    [Abstract] [Full Text] [Related]

  • 6. Differential involvement of 5-HT(1A) and 5-HT(1B/1D) receptors in human interferon-alpha-induced immobility in the mouse forced swimming test.
    Zhang H, Wang W, Jiang Z, Shang J, Zhang L.
    Arzneimittelforschung; 2010 Dec 15; 60(3):109-15. PubMed ID: 20422941
    [Abstract] [Full Text] [Related]

  • 7. Mechanism of action of the bimodal antidepressant vilazodone: evidence for serotonin1A-receptor-mediated auto-augmentation of extracellular serotonin output.
    van Amsterdam C, Seyfried CA.
    Psychopharmacology (Berl); 2014 Jun 15; 231(12):2547-58. PubMed ID: 24419272
    [Abstract] [Full Text] [Related]

  • 8. Role of 5-HT(1A) receptors in fluoxetine-induced lordosis inhibition.
    Guptarak J, Sarkar J, Hiegel C, Uphouse L.
    Horm Behav; 2010 Jul 15; 58(2):290-6. PubMed ID: 20223238
    [Abstract] [Full Text] [Related]

  • 9. 5-HT receptors couple to activation of Akt, but not extracellular-regulated kinase (ERK), in cultured hippocampal neurons.
    Cowen DS, Johnson-Farley NN, Travkina T.
    J Neurochem; 2005 May 15; 93(4):910-7. PubMed ID: 15857394
    [Abstract] [Full Text] [Related]

  • 10. 5-HT1A receptor-mediated phosphorylation of extracellular signal-regulated kinases (ERK1/2) is modulated by regulator of G protein signaling protein 19.
    Wang Q, Terauchi A, Yee CH, Umemori H, Traynor JR.
    Cell Signal; 2014 Sep 15; 26(9):1846-52. PubMed ID: 24793302
    [Abstract] [Full Text] [Related]

  • 11. Effects of postmortem delay on serotonin and (+)8-OH-DPAT-mediated inhibition of adenylyl cyclase activity in rat and human brain tissues.
    Palego L, Giromella A, Marazziti D, Borsini F, Naccarato AG, Giannaccini G, Lucacchini A, Cassano GB, Mazzoni MR.
    Brain Res; 1999 Jan 16; 816(1):165-74. PubMed ID: 9878719
    [Abstract] [Full Text] [Related]

  • 12. Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone.
    Hughes ZA, Starr KR, Langmead CJ, Hill M, Bartoszyk GD, Hagan JJ, Middlemiss DN, Dawson LA.
    Eur J Pharmacol; 2005 Mar 07; 510(1-2):49-57. PubMed ID: 15740724
    [Abstract] [Full Text] [Related]

  • 13. Synthesis and molecular modeling of new 1-aryl-3-[4-arylpiperazin-1-yl]-1-propane derivatives with high affinity at the serotonin transporter and at 5-HT(1A) receptors.
    Orús L, Pérez-Silanes S, Oficialdegui AM, Martínez-Esparza J, Del Castillo JC, Mourelle M, Langer T, Guccione S, Donzella G, Krovat EM, Poptodorov K, Lasheras B, Ballaz S, Hervías I, Tordera R, Del Río J, Monge A.
    J Med Chem; 2002 Sep 12; 45(19):4128-39. PubMed ID: 12213056
    [Abstract] [Full Text] [Related]

  • 14. Loss of Adult 5-HT1A Autoreceptors Results in a Paradoxical Anxiogenic Response to Antidepressant Treatment.
    Turcotte-Cardin V, Vahid-Ansari F, Luckhart C, Daigle M, Geddes SD, Tanaka KF, Hen R, James J, Merali Z, Béïque JC, Albert PR.
    J Neurosci; 2019 Feb 20; 39(8):1334-1346. PubMed ID: 30552180
    [Abstract] [Full Text] [Related]

  • 15. Activity of serotonin (5-HT) receptor agonists, partial agonists and antagonists at cloned human 5-HT1A receptors that are negatively coupled to adenylate cyclase in permanently transfected HeLa cells.
    Pauwels PJ, Van Gompel P, Leysen JE.
    Biochem Pharmacol; 1993 Jan 26; 45(2):375-83. PubMed ID: 8382063
    [Abstract] [Full Text] [Related]

  • 16. Selective serotonin reuptake inhibitors potentiate the rapid antidepressant-like effects of serotonin4 receptor agonists in the rat.
    Lucas G, Du J, Romeas T, Mnie-Filali O, Haddjeri N, Piñeyro G, Debonnel G.
    PLoS One; 2010 Feb 16; 5(2):e9253. PubMed ID: 20169084
    [Abstract] [Full Text] [Related]

  • 17. Activation of 5-HT(1A) autoreceptors enhances the inhibitory effect of galanin on hippocampal 5-HT release in vivo.
    Yoshitake T, Yoshitake S, Yamaguchi M, Ogren SO, Kehr J.
    Neuropharmacology; 2003 Feb 16; 44(2):206-13. PubMed ID: 12623219
    [Abstract] [Full Text] [Related]

  • 18. Delta(9)-tetrahydrocannabinol prolongs the immobility time in the mouse forced swim test: involvement of cannabinoid CB(1) receptor and serotonergic system.
    Egashira N, Matsuda T, Koushi E, Higashihara F, Mishima K, Chidori S, Hasebe N, Iwasaki K, Nishimura R, Oishi R, Fujiwara M.
    Eur J Pharmacol; 2008 Jul 28; 589(1-3):117-21. PubMed ID: 18565508
    [Abstract] [Full Text] [Related]

  • 19. The role of activation of the 5-HT1A receptor and adenylate cyclase in the antidepressant-like effect of YL-0919, a dual 5-HT1A agonist and selective serotonin reuptake inhibitor.
    Qin JJ, Chen HX, Zhao N, Yuan L, Zhang YZ, Yang RF, Zhang LM, Li YF.
    Neurosci Lett; 2014 Oct 17; 582():104-8. PubMed ID: 25220701
    [Abstract] [Full Text] [Related]

  • 20. Regulation of cortical and hippocampal 5-HT(1A) receptor function by corticosterone in GR+/- mice.
    Hensler JG, Vogt MA, Gass P.
    Psychoneuroendocrinology; 2010 Apr 17; 35(3):469-74. PubMed ID: 19766402
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.